Retail Roundup

Monday, December 5, 2016

This episode features David J. Fong, PharmD, former retail pharmacy senior executive who is now president of Dave Fong Rx Consulting, Inc., discussing trends and top opportunities likely to impact the retail pharmacy industry in the coming year, including:

  • DIR fees
  • Pharmacist provider status
  • Telehealth
  • Hospital-retail partnerships
  • Biosimilars
  • Opioid epidemic

Subscribe and Download this Podcast on iTunes

Visit iTunes Channel

You may also like:

Blog Post

Results released last month from the 2019 J.D. Power  U.S. Pharmacy Satisfaction Study showed that patients enjoy visiting brick-and-mort...

View Blog Post
Blog Post

Many providers and pharmacists are already well into influenza vaccination season, as they and the healthcare organizations for which they work have (rightly!) been encouraging patients to get vaccinated since early September (...

View Blog Post
Blog Post

CBD (cannabidiol) is widely available in stores and on the Internet and is often viewed a perfect solution for all sorts of ailments, since it acts similarly to cannabis, but without the THC that gives the high or stoned feelin...

View Blog Post

Filter by Type

Sign up to receive the latest news and information!

Sign Up